Literature DB >> 31149199

MULTIGLANDULAR PARATHYROID GLAND DISEASE: AN INCIDENTAL DISCOVERY IN NORMOCALCEMIC PATIENTS DURING THYROID SURGERY.

S M Cherenko1, A Dinets2, G V Bandura1, S A Sheptuha1, O S Larin1.   

Abstract

CONTEXT: Several enlarged parathyroid glands could be found during thyroid surgery in normocalcemic patients without evidence of primary or secondary hyperparathyroidism, indicating multiglandular parathyroid gland disease (MGD).
OBJECTIVE: Clinical role of various levels of serum ionized calcium (Ca2+) in patients diagnosed with incidental MGD during thyroid surgery remains controversial. The aim of the study was to evaluate the features of PHPT and the clinical role of serum Ca2+ in normocalcemic patients diagnosed with incidental MGD. STUDY
DESIGN: A prospective study of patients with normal preoperative Ca2+ to be operated on for thyroid diseases in 2010-2013 and diagnosed with MGD during thyroid surgery.
METHODS: An analysis of clinical data from 3,561 patients to be surgically treated for thyroid diseases revealed 219 (6%) patients with MGD and normal serum Ca2+. Further data analyses showed patients with MGD and high normal (≥1.25 - 1.3 mmol/L) serum Ca2+ (n = 89) and with moderate-low (1.0 - 1.24 mmol/L) serum Ca2+ (n = 130).
RESULTS: Primary hyperparathyroidism was diagnosed intra- and post-operatively in 48 (54%) patients with high-normal serum Ca2+ and in 2 (2%) patients with moderate-low serum Ca2+ (p<0.0001). Parathyroid hormone, serum Ca2+ as well as urine calcium excretion were elevated in 2 (2%) patients with moderate-low serum Ca2+ and in 18 (20%) patients with high-normal Ca2+ at follow-up (p<0.0001).
CONCLUSION: Serum Ca2+ level within the normal range, but higher than 1.25 mmol/L (high-normal) is associated with primary hyperparathyroidism, which should be considered in patients with visually diagnosed MGD, but without clinical symptoms of hyperparathyroidism.

Entities:  

Keywords:  multiglandular parathyroid disease; normocalcemic; parathyroid enlargement; thyroid surgery

Year:  2017        PMID: 31149199      PMCID: PMC6516574          DOI: 10.4183/aeb.2017.349

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  25 in total

1.  Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience.

Authors:  P G Gauger; G Agarwal; B G England; L W Delbridge; K A Matz; M Wilkinson; B G Robinson; N W Thompson
Journal:  Surgery       Date:  2001-12       Impact factor: 3.982

2.  Screening for primary hyperparathyroidism before thyroid surgery: A prospective study.

Authors:  Anne Denizot; Frédéric Dadoun; Anne Meyer-Dutour; Pierre Alliot; Maxime Argème
Journal:  Surgery       Date:  2002-03       Impact factor: 3.982

Review 3.  Frozen section of thyroid and parathyroid specimens.

Authors:  Rose C Anton; Thomas M Wheeler
Journal:  Arch Pathol Lab Med       Date:  2005-12       Impact factor: 5.534

4.  Unexpected findings during thyroid surgery in a regional community hospital: a 5-year experience of 738 consecutive cases.

Authors:  Jonathan S Lokey; Robert M Palmer; Jefferys A Macfie
Journal:  Am Surg       Date:  2005-11       Impact factor: 0.688

5.  Primary hyperparathyroidism--early diagnosis in patients referred for thyroid surgery.

Authors:  R A Wahl; F Hentschel; C Vorländer; J Schabram
Journal:  Langenbecks Arch Surg       Date:  2000-12       Impact factor: 3.445

6.  Management of primary hyperparathyroidism caused by multiple gland disease.

Authors:  P E Goretzki; C Dotzenrath; H D Roeher
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

7.  Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone.

Authors:  Gérard Maruani; Alexandre Hertig; Michel Paillard; Pascal Houillier
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

8.  Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxy vitamin D insufficiency.

Authors:  Todd D Beyer; Emery L Chen; Naris Nilubol; Richard A Prinz; Carmen C Solorzano
Journal:  J Surg Res       Date:  2007-07-25       Impact factor: 2.192

9.  Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.

Authors:  Sebastian Niedźwiecki; Krzysztof Kuzdak; Krzysztof Kaczka; Lech Pomorski
Journal:  Wiad Lek       Date:  2007

10.  Enlarged parathyroid glands discovered in normocalcemic patients during thyroid surgery.

Authors:  Bassam Abboud; Ghassan Sleilaty; Carla Braidy; Claude Ghorra; Gerard Abadjian; Cyril Tohme; Roger Noun; Riad Sarkis
Journal:  Am J Surg       Date:  2008-01       Impact factor: 2.565

View more
  2 in total

1.  ARE THYROID NODULES AN OBSTACLE TO MINIMAL INVASIVE PARATHYROID SURGERY? A SINGLE-CENTER STUDY FROM AN ENDEMIC GOITER REGION.

Authors:  S Özden; B Saylam; G Daglar; Y N Yuksek; M Tez
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Oct-Dec       Impact factor: 0.877

2.  Challenges of Differential Diagnosis Between Primary Hyperparathyroidism and Bone Metastases of Breast Cancer.

Authors:  Maksym Gorobeiko; Andrii Dinets; Denys Pominchuk; Karim Abdalla; Yuriy Prylutskyy; Viktoria Hoperia
Journal:  Clin Med Insights Case Rep       Date:  2022-09-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.